Results 131 to 140 of about 61,737 (200)

In silico prediction, molecular docking and simulation of natural flavonoid apigenin and xanthoangelol E against human metapneumovirus. [PDF]

In Silico Pharmacol
Rahaman HH, Khan A, Sharif N, Ahmed W, Sharif N, Majumder R, Obregon SA, Iglesias RC, De la Torre Díez I, Dey SK.   +9 more
europepmc   +1 more source

New insight into the epidemiological trends of respiratory syncytial virus infection and the underlying anti-respiratory syncytial virus mechanisms of andrographolide: integrating Global Burden of Disease database, network pharmacological analysis, and <i>in vitro</i> experiments. [PDF]

Microbiol Spectr
Huang L, Halihaman B, Han Y, Zhou J, Liu C, Bai H, Ding X.   +6 more
europepmc   +1 more source

Pediatric efficacy and safety in common cold treated with herbal medicine (PEACH): a systematic review and meta-analysis. [PDF]

Front Pharmacol
Kim SD, Lee SW, Woo SC, Kim DH, Jun LK, Kim JH, Yang DY, Kang BG, Park YC, Lee B, Lyu YR.   +10 more
europepmc   +1 more source

Why does the world continue to struggle with effectively addressing hepatitis E? [PDF]

EXCLI J
Borges da Silva Grisard H, Fongaro G.
europepmc   +1 more source

Research progress on antiviral drugs and vaccines for severe fever with thrombocytopenia syndrome. [PDF]

Front Immunol
Chen C, Li J, Li J, Huang R, Chen C, Xu J, Zhang Y, Lou Y.   +7 more
europepmc   +1 more source

Direct-acting antivirals for chronic hepatitis C infection: a protocol for a systematic review of observational studies. [PDF]

Syst Rev
Kumburegama BWMB, Kristensen AT, Bjelakovic G, Nikolova D, Asante MA, Bjelakovic M, Koretz RL, Balakumar MM, Michelsen ME, Klingenberg SL, Gluud C.   +10 more
europepmc   +1 more source

Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Teymourzadeh E, Salesi M, Keshavarz K, Abyazi MA, Heiat M, Alavian SM.   +7 more
europepmc   +1 more source

Efficacy of Sofosbuvir-Velpatasvir-Ribavirin Regimen for Retreatment of Chronic Hepatitis C in Patients With Prior DAA Failure: A Retrospective Study From a National Treatment Center. [PDF]

Int J Hepatol
Singh S, Sengupta S, Kumar D, Mukherjee K, Hasan AMD, Sadhukhan P, Ahammed SM.   +6 more
europepmc   +1 more source

Respiratory Viral Infection Prophylaxis and Treatment in the Transplant Population. [PDF]

Viruses
Giuliani AAM, Chen V, Law N.
europepmc   +1 more source